Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

Investment analysts at Leerink Partnrs reduced their FY2028 earnings per share estimates for shares of Inspire Medical Systems in a report released on Tuesday, February 11th. Leerink Partnrs analyst M ...

Revenue for Q4 2024 was $239.7 million, marking a 25% year-over-year increase. Net income reached $35.2 million compared to $14.8 million in Q4 2023. Herbert reiterated the 2025 revenue guidance of ...

MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...

Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report) gapped down before the market opened on Tuesday after Truist Financial lowered their price target on the stock from $250.00 to $235.00. The ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 24.5% year on year to $239.7 million.

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inspire Medical Systems (INSP – Research ...

Inspire Medical Systems ( INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Chairman and Chief Executive Officer of Inspire Medical Systems. "During the quarter, we made steady progress toward the full launch of Inspire V, optimized our leadership team to fuel future ...